EA
ANGO icon

Emerald Acquisition’s AngioDynamics ANGO Stock Holding History

Emerald Acquisition’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$263K Sell
14,991
-1,571
-9% -$25.5K ﹤0.01% 2632
2016
Q2 		$238K Buy
+16,562
New +$207K ﹤0.01% 2692

Other funds holding ANGO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Emerald Acquisition's ANGO Position: Q3 2016 in Review

Emerald Acquisition reduced its AngioDynamics (ANGO) stake by 9.5% in Q3 2016, selling an estimated $25.5K and leaving 14,991 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2632.

Emerald Acquisition first reported a position in ANGO in Q2 2016 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold ANGO as of Q3 2016.

  • Emerald Acquisition held 14,991 shares of AngioDynamics worth $263K as of Q3 2016.
  • Emerald Acquisition sold 1,571 AngioDynamics shares in Q3 2016, an estimated $25.5K.
  • AngioDynamics made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2632 holding.
  • Emerald Acquisition first reported a position in AngioDynamics in Q2 2016 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.